 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Noble James
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-05-24 Sale | 2019-05-29 8:00 pm | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 82,596 | $15.32 | $1,265,083 | 27,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2016-01-18 Option Award | 2016-01-20 4:30 pm | N/A 2026-01-18 | Adaptimmune Therapeutics PLC | ADAP | Noble James CEO | 1,968,016 | $1.2717 | 1,968,016 (Direct) | View |
| 2017-01-13 Option Award | 2017-01-18 5:00 pm | N/A 2027-01-13 | Adaptimmune Therapeutics PLC | ADAP | Noble James CEO | 2,072,976 | $0.72 | 2,072,976 (Direct) | View |
| 2018-01-12 Option Award | 2018-01-17 5:20 pm | N/A 2028-01-12 | Adaptimmune Therapeutics PLC | ADAP | Noble James CEO | 1,719,936 | $1.3 | 384,120 (Direct) | View |
| 2018-01-12 Option Award | 2018-01-17 5:20 pm | N/A 2028-01-12 | Adaptimmune Therapeutics PLC | ADAP | Noble James CEO | 384,120 | $0.0014 | 384,120 (Direct) | View |
| 2019-01-04 Option Award | 2019-01-08 9:00 pm | N/A 2029-01-04 | Adaptimmune Therapeutics PLC | ADAP | Noble James CEO | 2,515,536 | $0.89 | 561,792 (Direct) | View |
| 2019-01-04 Option Award | 2019-01-08 9:00 pm | N/A 2029-01-04 | Adaptimmune Therapeutics PLC | ADAP | Noble James CEO | 561,792 | $0.0013 | 561,792 (Direct) | View |
| 2019-03-01 Option Award | 2019-03-05 9:05 pm | 2022-03-01 2029-03-01 | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 16,548 | $14.33 | 3,144 (Direct) | View |
| 2019-03-01 Option Award | 2019-03-05 9:05 pm | 2020-03-01 2029-03-01 | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 3,144 | $0.0013 | 3,144 (Direct) | View |
| 2019-03-01 Option Award | 2019-03-05 9:05 pm | 2021-03-01 2029-03-01 | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 3,144 | $0.0013 | 3,144 (Direct) | View |
| 2019-03-01 Option Award | 2019-03-05 9:05 pm | 2022-03-01 2029-03-01 | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 3,144 | $0.0013 | 3,144 (Direct) | View |
| 2019-05-16 Exercise | 2019-05-17 6:00 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Noble James CEO | 1,773,100 | $0.143 | 1,773,100 (Direct) | View |
| 2019-05-24 Exercise | 2019-05-29 8:00 pm | N/A N/A | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 14,479 | $0.0013 | 27,500 (Direct) | View |
| 2019-05-24 Exercise | 2019-05-29 8:00 pm | N/A N/A | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 68,117 | $4.8641 | 27,500 (Direct) | View |
| 2019-05-24 Exercise | 2019-05-29 8:00 pm | 2018-12-29 2025-12-29 | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 14,479 | $0.0013 | 27,500 (Direct) | View |
| 2019-05-24 Exercise | 2019-05-29 8:00 pm | 2018-12-29 2025-12-29 | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 34,061 | $4.8641 | 27,500 (Direct) | View |
| 2019-05-24 Exercise | 2019-05-29 8:00 pm | 2018-12-29 2025-12-29 | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 34,056 | $4.8641 | 27,500 (Direct) | View |
| 2020-01-13 Sale | 2020-01-15 8:01 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Noble James Director | 100,000 | $4 | 0 (Direct) | View |
| 2020-01-13 Sale | 2020-01-15 8:01 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Noble James Director | 200,000 | $5 | 0 (Direct) | View |
| 2020-04-01 Option Award | 2020-04-01 7:06 pm | 2021-04-01 2030-04-01 | Adaptimmune Therapeutics PLC | ADAP | Noble James Director | 31,000 | $0.45 | 31,000 (Direct) | View |
| 2020-05-29 Sale | 2020-06-02 9:30 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Noble James Director | 500,000 | $9.332 | 0 (Direct) | View |
| 2020-06-04 Option Award | 2020-06-08 8:05 pm | N/A 2030-06-04 | GW PHARMACEUTICALS PLC | GWPH | Noble James Director | 34,416 | $0.0013 | 34,416 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-01 5:08 pm | 2021-07-01 2030-07-01 | Adaptimmune Therapeutics PLC | ADAP | Noble James Director | 179,785 | $1.67 | 179,785 (Direct) | View |